Pharmalittle: Merck will help J&J make its Covid-19 vaccine; Trump used hospital funds to bankroll Warp Speed

first_img By Ed Silverman March 2, 2021 Reprints Pharmalot Pharmalot Columnist, Senior Writer Ed covers the pharmaceutical industry. @Pharmalot Daily reporting and analysis The most comprehensive industry coverage from a powerhouse team of reporters Subscriber-only newsletters Daily newsletters to brief you on the most important industry news of the day STAT+ Conversations Weekly opportunities to engage with our reporters and leading industry experts in live video conversations Exclusive industry events Premium access to subscriber-only networking events around the country The best reporters in the industry The most trusted and well-connected newsroom in the health care industry And much more Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr. Tags STAT+ Log In | Learn More Alex Hogan/STAT STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond. What is it?center_img Unlock this article — plus daily coverage and analysis of the pharma industry — by subscribing to STAT+. First 30 days free. GET STARTED Ed Silverman About the Author Reprints Rise and shine, another busy day is on the way. We can tell because our short person is hunched over a laptop for another round of learning and our official mascot is bounding about the grounds while barking at critters. As for us, we are rifling through our fast-growing to-do list and brewing cups of stimulation. Our choice today is maple bourbon. Yes, this is a real flavor. Feel free to join us. Or grab a bottle of water, if you prefer. Meanwhile, here are some tidbits. We hope your day goes well, and do stay safe — wear a mask. …Merck (MRK) will help Johnson & Johnson (JNJ) make its single-shot Covid-19 vaccine, an unusual pact between competitors that could boost the supply of the newly authorized shot, The Washington Post reports. Biden administration officials began searching for additional manufacturing capacity after they realized that J&J had fallen behind in vaccine production and sought to broker a deal with Merck, which had failed to develop its own coronavirus vaccine. Pharmalittle: Merck will help J&J make its Covid-19 vaccine; Trump used hospital funds to bankroll Warp Speed What’s included? [email protected] GET STARTEDlast_img read more